Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
ELMO2 Antibody, PH domain protein CED12A Antibody, CED-12 Antibody, Ced-12 homolog 2 Antibody, CED12 Antibody, CED12A Antibody, ELMO-2 Antibody, Engulfment and cell motility 2 Antibody, HCed-12A Antibody, KIAA1834 Antibody, Protein ced-12 homolog A Antibody
Involved in cytoskeletal rearrangements required for phagocytosis of apoptotic cells and cell motility. Acts in assocation with DOCK1 and CRK. Was initially proposed to be required in complex with DOCK1 to activate Rac Rho small GTPases. May enhance the guanine nucleotide exchange factor (GEF) activity of DOCK1.
ELMO2 Antibody immunohistochemistry of formalin-fixed and paraffin-embedded human skeletal muscle followed by peroxidase-conjugated secondary antibody and DAB staining.
ELMO2 Antibody western blot of Jurkat cell line lysates (35 ug/lane). The ELMO2 antibody detected the ELMO2 protein (arrow).
ELMO2 Antibody flow cytometry of Jurkat cells (right histogram) compared to a negative control cell (left histogram). FITC-conjugated donkey-anti-rabbit secondary antibodies were used for the analysis.
Requested From: United States
Date Requested: 10/25/2016